Advertisement Hikma introduces therapeutic heparin in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Hikma introduces therapeutic heparin in US

Hikma Pharmaceuticals, a provider of generic products, has introduced therapeutic heparin in the US in single and multiple does vials.

Heparin is used to prevent clot formation in central venous catheters and is also used as an anticoagulant (blood thinning) therapy.

Heparin is availble in five new vial presentations in volume from 1 milliliter (mL) to 30 mL, and in concentration from 1,000 units per mL to 10,000 units per mL.